Skip to main content
Atrás
GERN logo

Geron Corporation

Calidad de datos: 100%
GERN
NASDAQ Healthcare Biotechnology
$1.54
▲ $0.08 (5.48%)
Cap. Mercado: 986.44M
Rango del Día
$1.47 $1.61
Rango de 52 Semanas
$1.04 $2.01
Volumen
19,570,526
Promedio 50D / 200D
$1.54 / $1.38
Cierre Anterior
$1.46

Historial de Precios

Tendencias Financieras

Comparación con Pares

vs mediana del sector Healthcare (626 pares)

Métrica Acción Mediana del Sector
P/E -11.5 0.4
P/B 4.4 2.9
ROE % -33.9 3.7
Net Margin % -46.7 3.8
Rev Growth 5Y % 239.0 10.0
D/E 1.1 0.2

Puntos Clave

Revenue grew 238.96% annually over 5 years — strong growth
Negative free cash flow of -111.09M
PEG of 0.20 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 100.13%
Capital efficient — spends only 0.03% of revenue on capex

Crecimiento

Revenue Growth (5Y)
238.96%
Revenue (1Y)138.83%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Calidad

Return on Equity
-33.89%
ROIC-8.46%
Net Margin-46.65%
Op. Margin-29.28%

Seguridad

Debt / Equity
1.11
Current Ratio4.66
Interest Coverage-1.65

Valoración

P/E Ratio
-11.50
P/B Ratio4.37
EV/EBITDAN/A
Dividend Yield0.00%

All Fundamental Metrics

Growth
Revenue Growth (1Y) 138.83% Revenue Growth (3Y) 2685.44%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 238.96% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 183.88M Net Income (TTM) -85.78M
ROE -33.89% ROA -15.04%
Gross Margin 97.42% Operating Margin -29.28%
Net Margin -46.65% Free Cash Flow (TTM) -111.09M
ROIC -8.46% FCF Growth (3Y) N/A
Safety
Debt / Equity 1.11 Current Ratio 4.66
Interest Coverage -1.65 Dividend Yield 0.00%
Valuation
P/E Ratio -11.50 P/B Ratio 4.37
P/S Ratio 5.36 PEG Ratio 0.20
EV/EBITDA N/A Dividend Yield 0.00%
Market Cap 986.44M Enterprise Value 1.16B

Income Statement

Annual, most recent first

Income statement data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 183.88M 76.99M 237,000.0 596,000.0 1.39M
Net Income -85.78M -174.57M -184.13M -141.90M -116.11M
EPS (Diluted) -0.13 -0.27 -0.32 -0.37 -0.37
Gross Profit 179.14M 75.74M 237,000.0 596,000.0 1.39M
Operating Income -53.84M -173.73M -193.94M -138.55M -114.00M

Balance Sheet

Annual, most recent first

Balance sheet data, annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 570.54M 593.78M 394.08M 190.58M 226.03M
Total Liabilities 344.67M 313.46M 146.13M 110.58M 99.62M
Shareholders' Equity 225.87M 280.32M 247.95M 80.00M 126.42M
Total Debt 251.57M 121.72M 85.90M 55.75M 55.00M
Cash & Equivalents 79.44M 79.02M 70.02M 56.85M 34.87M
Current Assets 520.27M 490.99M 341.35M 180.25M 187.21M
Current Liabilities 111.54M 88.30M 108.07M 76.69M 45.52M

Puntuaciones de Estrategias

This stock passed the criteria for 1 strategy

Score = fit strength (0–100)
Rank = position among all matches
Custom Full Throttle
#19 of 146
66

Actividad Reciente

Entró Full Throttle
Mar 24, 2026